Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Fixed Capital/Sales

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.850.740.901.040.77

What is the latest Fixed Capital/Sales ratio of MEDICAMEN BIOTECH ?

The latest Fixed Capital/Sales ratio of MEDICAMEN BIOTECH is 0.85 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.85
Mar20240.74
Mar20230.90
Mar20221.04
Mar20210.77

How is Fixed Capital/Sales of MEDICAMEN BIOTECH Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.85
14.86
Mar2024 0.74
-17.78
Mar2023 0.9
-13.46
Mar2022 1.04
35.06
Mar2021 0.77 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare Fixed Capital/Sales ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹488.7 Cr 13% 8.5% -26.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,471.0 Cr 0.3% 4.1% -9.9% Stock Analytics
DIVIS LABORATORIES ₹172,294.0 Cr -1.7% 8.5% 13.2% Stock Analytics
CIPLA ₹127,946.0 Cr -3.4% 3% 4.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,691.0 Cr 0.7% -0.5% 7.2% Stock Analytics
DR REDDYS LABORATORIES ₹107,214.0 Cr 0.2% -1.1% -3.6% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

13%

8.5%

-26.9%

SENSEX

1%

3.3%

4.5%


You may also like the below Video Courses